Sandra Mascarenhas-Rodrigues
Joao Pessoa, PB 58051900, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Ouabain exerts protective effects on SH-SY5Y cells upon Zika virus infection.
Journal: Virology journal
Published: October 19, 2025
Immunosuppressive effects of the mycotoxin patulin in macrophages.
Journal: Archives of microbiology
Published: January 25, 2024
Zika virus: Antiviral immune response, inflammation, and cardiotonic steroids as antiviral agents.
Journal: International immunopharmacology
Published: October 10, 2023
Ouabain modulates airway remodeling caused by Th2-high asthma in mice.
Journal: International immunopharmacology
Published: January 27, 2022
Antiviral activity of ouabain against a Brazilian Zika virus strain.
Journal: Scientific reports
Published: October 15, 2021
Ouabain inhibits p38 activation in mice neutrophils.
Journal: Inflammopharmacology
Published: August 11, 2021
Neutrophils and COVID-19: The road so far.
Journal: International immunopharmacology
Published: September 17, 2020
Morita-Baylis-Hillman Adduct 2-(3-Hydroxy-2-oxoindolin-3-yl)acrylonitrile (ISACN) Modulates Inflammatory Process In vitro and In vivo.
Journal: Inflammation
Published: May 29, 2020
The pterocarpanquinone LQB 118 inhibits inflammation triggered by zymosan in vivo and in vitro.
Journal: International immunopharmacology
Published: October 15, 2019
Ouabain reduces the expression of the adhesion molecule CD18 in neutrophils.
Journal: Inflammopharmacology
Published: December 18, 2018
Author Correction: Ouabain attenuates ovalbumin-induced airway inflammation.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: January 18, 2018
Ouabain attenuates ovalbumin-induced airway inflammation.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: May 08, 2017
Last Updated: 09/26/2026